VaLogic Bio News and Updates
Contact Us What Lab Data Integrity Actually Requires (And Where Teams Fall Short) Data integrity is one of the most frequently cited areas in both FDA warning letters and Form 483 observations. Yet many quality teams still treat it as a documentation exercise rather than a systems discipline. Understanding what data integrity actually requires, not … Read more
Contact Us OOS Investigations: What FDA Expects and Where Programs Break Down An out-of-specification result is not itself a compliance failure. How you investigate it determines whether you have a defensible quality system or a vulnerability waiting to be cited. FDA’s guidance on investigating OOS laboratory test results, first issued in 2006 and still the … Read more
Contact Us Root Cause Analysis: Going Beyond the Obvious When a deviation occurs, the pressure to close it quickly is real. There are timelines to meet, batches waiting for disposition, and auditors who will ask about open CAPAs. That pressure often pushes investigation teams toward the most convenient explanation rather than the most accurate one. … Read more
Contact Us The Complete Deviation Workflow: Detection to Effective CAPA Deviations are inevitable in pharmaceutical manufacturing. Equipment behaves unexpectedly. Human errors occur. Environmental conditions fall outside acceptable ranges. The presence of deviations is not a sign of a failing quality system; how deviations are handled is what matters. A complete deviation workflow is not just … Read more
Contact Us Template vs. Tailored: When to Customize Your Validation Approach Templates save time. That is their entire value proposition. A well-designed validation template gives your team a consistent starting point, reduces drafting time, and helps ensure that required elements are not overlooked. But templates also carry a risk: they can become a substitute for … Read more
Contact Us The Regulatory Roadmap: FDA, EMA, and MHRA Alignment Strategies Your site just received notice of an upcoming FDA inspection. Great—you’ve been preparing for months. But you also supply to EU and UK markets. Your EMA inspection is next quarter, and MHRA might show up anytime after that. Now you’re managing three inspection preparation … Read more
Contact Us The Anatomy of an Effective Validation Protocol: 8 Essential Elements Validation protocols are the backbone of pharmaceutical compliance. They define what you will test, how you will test it, and what a passing result looks like. But many protocols fall short not because the science is wrong, but because the document itself is … Read more
Contact Us Mapping Your QMS: Where Does Your Documentation Actually Live? If I asked you right now, “Where is your validation master plan?” could you answer in under 10 seconds? What about your critical process SOPs? Your completed batch records from two years ago? If you hesitated, you’re not alone. One of the most common … Read more
Contact Us Key Tests in the Cleanroom Certification Process Cleanroom certification is a critical foundation for ensuring safe, consistent, and compliant operations across life sciences, pharmaceuticals, and advanced manufacturing. Whether you’re managing sterile drug production, assembling sensitive microelectronics, or manufacturing cell and gene therapies, cleanroom testing provides objective verification that your environment supports rigorous quality … Read more
Contact Us The Scope of Environmental Monitoring for Cleanroom Compliance Environmental monitoring (EM) systems are a critical tool for maintaining control over cleanroom compliance, allowing you to catch potential issues before they affect your bottom line. This article explores the full scope of cleanroom environmental monitoring services—from airborne particles and viable surface swabs to compressed … Read more